Johnson & Johnson
Johnson & Johnson (J&J) is an American multinational, pharmaceutical, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.
Headquarters at One Johnson and Johnson Plaza in New Brunswick, New Jersey | |
| Company type | Public |
|---|---|
Traded as | |
| ISIN | US4781601046 |
| Industry |
|
| Founded | January 1886 in New Brunswick, New Jersey, United States |
| Founders |
|
| Headquarters | Johnson and Johnson Plaza, New Brunswick, New Jersey , |
Area served | Worldwide |
Key people |
|
| Products | List of Johnson & Johnson products and services |
| Revenue | US$85.16 billion (2023) |
| US$21.21 billion (2023) | |
Net income | US$35.15 billion (2023) |
| Total assets | US$167.6 billion (2023) |
| Total equity | US$68.78 billion (2023) |
Number of employees | 134,400 (2023) |
| Subsidiaries | |
| Website | jnj.com |
| Footnotes / references | |
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split off its consumer healthcare business sector into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.
Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.